HAEMOVIGILANCE AND SAFE BLOOD TRANSFUSION
Abstract
Background. Haemovigilance is a system consisting of the detection, collecting and analysis of information regarding unwanted and unexpected effects of blood transfusion that make it possible to take action in order to improve blood trasfusion safety. In a broader sense, it is defined as a set of surveillance procedures covering the whole transfusion chain from the collection of blood to the follow-up of recipients. In some European countries a haemovigilance system based on legislation was introduced during the last ten years, European Haemovigilance Network was organised and some results from the existing surveillance systems were reported. The paper presents haemovigilance activities in Slovenia.
Conclusions. In Slovenia, many elements of haemovigilance are already included in the blood transfusion chain, but no unique system of data collection exists. We expect a new legislation on blood transfusion to help us with introducing a data collection system, analysis and activities in order to further improve blood transfusion safety.
Downloads
References
Strengers FW. Haemovigilance – why? Zbornik 5. podiplomski seminar Zdravljenje s krvjo. Portorož, 12.–14. 12. 2002. Ljubljana: Zavod RS za transfuzijsko medicino, Klinični center Ljubljana, ESTM – Evropska šola za transfuzijsko medicino, 2002: 102–9.
Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30: 583–90.
Linden JV et al. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601–6.
Williamson LM, Love S, Love E et al. Serious hazards of transfusion (SHOT) Initiative: analysis of the first two annual reports. Brit Med J 1999; 319: 16–9.
Strengers PFW. What is haemovigilance? The European haemovigilance network (EHN). Proceedings of the ESTM residential course: Basic clinical and organisational requirements for an effective haemovigilance. Sofia, 28.– 30. 11. 2002. Sofia: ESTM, 2002: 3–6.
Faber JC. Haemovigilance around the world. Vox Sang 2002; 83: Suppl 1: 71–6.
Faber JC. Haemovigilance in Europe: the European haemovigilance network. Transfus Clini Biol 2001; 8: 285–90.
Svet Evrope. Priporočilo o pripravi, uporabi in zagotavljanju kakovosti komponent krvi. 9. izd. Strassbourg: Svet Evrope. Zavod RS za transfuzijo krvi, Informacijsko dokumentacijski center Sveta Evrope pri NUK v Ljubljani, 2003: 227–34.
Pravilnik o farmakovigilanci. Ur. list RS, 2000; št. 94.
Zakon o zdravilih in medicinskih pripomočkih. Ur. list RS 16. 12. 1999, št. 101: 15013–27.
Zakon o preskrbi s krvjo. Ur. list RS 13. 6. 2000, št. 52; 6943–8.
Direktiva 2002 ES Evropskega parlamenta in Sveta za določitev standardov kakovosti in varnosti za zbiranje oz. odvzem, testiranje, predelavo, shranjevanje in distribucijo človeške krvi in sestavin krvi ter dopolnitev. Direktive 2001; 83.
Svet republiškega zdravstvenega centra. Strokovno navodilo o ravnanju s krvjo v bolnišničnih oddelkih in o pripravi na transfuzijo. Ljubljana: Republiški zdravstveni center, 1968.
Zavod RS za transfuzijo krvi. Navodila za delo v transfuzijski dejavnosti. Ljubljana: Zavod RS za transfuzijo krvi, 1992: 30–2.
Engelfriet CP, Reesink HW. Haemovigilance systems. Vox Sang 1999; 77: 67–76.
Domanovič D. Hemovigilanca. Zdravljenje s krvjo v kirurgiji. Zbornik 3. podiplomskega seminarja. Portorož 2000. Ljubljana: Sekcija za transfuzijsko medicino SZD, 2000: 80–6.
Hellenic Ministery of Health and Social welfare. The Hellenic Coordinating Haemovigilance Centre (SKAE). Serious adverse events associated with blood transfusion (1997–2000). Athens, October 2001. Athens: SKAE, 2001.
Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Herve P. Haemovigilance network in France: organisation and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002; 42: 1356– 64.
Potočnik M. Report on clinical transfusion practice and haemovigilance in Slovenia. Proceedings of the ESTM residential course: Basic clinical and organisational requirements for an effective haemovigilance, Sofia, 28.–30. 11. 2002. Sofia: ESTM, 2002: 175–6.
Potočnik M. Hemovigilanca v Sloveniji. Zbornik 5. podiplomski seminar. Zdravljenje s krvjo. Portorož, 12.–14. 12. 2002. Ljubljana: Zavod RS za transfuzijsko medicino, Klinični center Ljubljana, ESTM – Evropska šola za transfuzijsko medicino. 2002: 148–50.
Potočnik M. Hemovigilanca. Ljubljana: Zavod za transfuzijsko medicino, Klinični center Ljubljana, 2002.
Pravilnik o vsebini vodene dokumentacije o uporabi krvi, krvnih pripravkov in zdravil iz krvi, vključno z biotehnološkimi nadomestki za kri. Ur. list RS, 18. 7. 2003, št. 70; 10817–8.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
